Tuesday 10 May 2016
Effective analysis is key for the successful continuous manufacturing of solid dosage pharmaceuticals.
More pharmaceutical companies are becoming interested in continuous processing, but they may face an “analytics gap,” because continuous will require a different approach to analytics. In Filing the Analysis Gap in the Move to Continuous Processing Jamie Clayton discusses issues and best approaches for solid dosage form pharmaceuticals.
Read this article in Pharmaceutical Technology’s 2016 Solid Dosage Drug Development and Manufacturing eBook.